Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Frelinger

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Plos One|April 23, 2021
Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobinBogdan Neculaes, Andrew L Frelinger, Anja J Gerrits, et al.
Atherosclerosis|November 22, 2021
Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterizationThomas Gremmel, Alan D Michelson, Patricia P Wadowski, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Plos One|September 27, 2018
Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphologyAndrew L Frelinger, Anja J Gerrits, V Bogdan Neculaes, et al.
Platelets|December 7, 2020
Platelet surface GPIbα, activated GPIIb-IIIa, and <i>P</i>-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patientsMichael Mazzeffi, Kenichi Tanaka, Yi-Feng Wu, et al.
Clinical and Translational Science|January 1, 2019
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled StudyRobert J Charnigo, David Beidler, Denis Rybin, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 22, 2011
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apneaShilpa Rahangdale, Susie Yim Yeh, Victor Novack, et al.
Platelets|October 27, 2009
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivityInge Tarnow, Alan D Michelson, Marc R Barnard, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Platelets|August 21, 2014
The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell diseaseJoseph A Jakubowski, Chunmei Zhou, Kenneth J Winters, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Plos One|April 23, 2021
Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobinBogdan Neculaes, Andrew L Frelinger, Anja J Gerrits, et al.
Atherosclerosis|November 22, 2021
Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterizationThomas Gremmel, Alan D Michelson, Patricia P Wadowski, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Plos One|September 27, 2018
Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphologyAndrew L Frelinger, Anja J Gerrits, V Bogdan Neculaes, et al.
Platelets|December 7, 2020
Platelet surface GPIbα, activated GPIIb-IIIa, and <i>P</i>-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patientsMichael Mazzeffi, Kenichi Tanaka, Yi-Feng Wu, et al.
Clinical and Translational Science|January 1, 2019
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled StudyRobert J Charnigo, David Beidler, Denis Rybin, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 22, 2011
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apneaShilpa Rahangdale, Susie Yim Yeh, Victor Novack, et al.
Platelets|October 27, 2009
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivityInge Tarnow, Alan D Michelson, Marc R Barnard, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Platelets|August 21, 2014
The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell diseaseJoseph A Jakubowski, Chunmei Zhou, Kenneth J Winters, et al.
Pageof 10